✦ LIBER ✦

531 - Cisplatin/paclitaxel vs carboplatin/paclitaxel: Optimizing of treatment in advanced ovarian cancer

✍ Scribed by V. Möbus; C. Jackisch; H.-J. Lück; W. Meier; T. Bauknecht; S. Costa; B. Richter; U. Nitz; A. du Bois

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel vs cyclophosphamide, + cispla

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Optimal therapy of advanced ovarian canc

✍ M. A. Bookman; B. E. Greer; R. F. Ozols 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Pharmacoeconomic analysis of advanced no

✍ C. Rubio-Terrés; J.L. Tisaire; S. Kobina; A. Moyano 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 351 KB

37 Paclitaxel plus carboplatin versus pa

✍ G. Aravantinos; G. Fountzlias; P. Kosmidis; Ma. Dimopoulos; Gp. Stathopoulos; N. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Topotecan, carboplatin + paclitaxel in o

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

DMXAA + carboplatin + paclitaxel in ovar

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB